TITLE

orlistat

AUTHOR(S)
Peters, Michael
PUB. DATE
June 2004
SOURCE
BMA A-Z Family Medical Encyclopedia;2004, p569
SOURCE TYPE
Book
DOC. TYPE
Reference Entry
ABSTRACT
An encyclopedia entry for "orlistat" is presented. It refers to an anti-obesity drug used with a slimming diet for the treatment of severe obesity. It is different from appetite suppressants in that orlistat acts on the gastrointestinal tract, preventing the digestion of fats by lipases. The fats, instead of being absorbed, pass out of the body in faeces. Among its side effects are flatulence and faecal urgency.
ACCESSION #
43999706

 

Related Articles

  • Anti Obesity Drugs. Huppertz, Christine // Encyclopedic Reference of Molecular Pharmacology;2004, p97 

    The article presents an encyclopedia entry for the term "anti-obesity drugs," which are drugs that help to control appetite and reduce weight. It discusses the mechanism of action of anti-obesity drugs. It also provides information on the clinical use and side effects of these drugs. Several...

  • ORLISTAT.  // Complete Guide to Prescription & Nonprescription Drugs 2012;2012, p622 

    The article presents information on orlistat, an antiobesity drug and lipase inhibitor, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • Antidote. Siegel, Marc // Medical Marketing & Media;Apr2006, Vol. 41 Issue 4, p14 

    The article examines some weight loss drugs in the United States. Xenical or Orlistat are drugs that hinder fat absorption into the gastrointestinal tract. An appetite suppressant, Meridia prevents the reabsorption of serotonin, a hormone in the brain that is released when a patient is full from...

  • DIET DOCTORS GONE WRONG. Sklar, Hallie Levine // Health (Time Inc.);Jun2011, Vol. 25 Issue 5, p112 

    The article focuses on the risky treatments provided by weight loss doctors and ways to seek safe treatment. The risky weight loss treatment issue is demonstrated in the case of Mary Lynn Adams, who experienced hypertension due to consuming appetite suppressant phentermine, which was prescribed...

  • Health Canada issues warning against the use of Slim.  // Reactions Weekly;1/13/2007, Issue 1134, p3 

    This article reports that Health Canada warned consumers against the use of Slim, a weight-loss product manufactured in China. The warning comes after the health department of Hong Kong, China issued similar advice amongst concerns that the product is adulterated with sibutramine, a prescription...

  • Not safe for slimming.  // Joe Weider's Muscle & Fitness;May99, Vol. 60 Issue 5, p38 

    Reports on the side effects of the diet drug sibutramine. Development of potentially dangerous hypertension; Abnormal heart rhythms; Higher pulse rates.

  • SECTION 7 METABOLIC DISORDERS.  // MPR - Pharmacist's Edition;Fall2014, Vol. 8 Issue 3, p131 

    The article offers information on several drugs for the treatment of obesity. The Belviq weight-loss medication from pharmaceutical firm Eisai Co. Ltd. should be used together with a reduced-calorie diet and weight maintenance to treat obesity. Obese patients are advised to take the Qsymia...

  • A pharmacologic approach to obesity. Lucas, Charles P.; Segal, Karen R.; Hauptman, Jonathan // Contemporary OB/GYN;Jun2000, Vol. 45 Issue 6, p18 

    Evaluates the effectiveness of orlistat for the treatment of obesity. Gender-specific effects of obesity; Effect of orlistat on weight loss; Side effects of orlistat. INSET: Fighting obesity.

  • Two Weight Loss Drugs-Meridia and Xenical The Pros and Cons of Each.  // HealthFacts;Feb2004, Vol. 29 Issue 2, p3 

    Compares weight loss drugs Meridia and Xenical. Details on how the two drugs work; Side effects experienced by users; Costs of the drugs.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics